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At the end of the eighteenth century, following the mid-
dle-class and industrial revolution, important urbaniza-
tion phenomena arose – dragging with them social and 
sanitary issues [1].
In this evolving historical scenario, tuberculosis spread 
quickly by taking advantage from rapid urbanization 
leading to metropolitan overcrowding combined with 
poor quality of hygienic conditions. Thus, tuberculosis 
became the first cause of death in Europe. 
At the end of the eighteenth century one citizen out of 
four was dying of tuberculosis in London and compa-
rable percentages were recorded in big cities of Northern 
America.
The causes of the disease were not yet clarified: the so 
called “scientific visions” supported the theory of a con-
genital disease, already argued by Hippocrates, opposed 
to the idea of an infectious and transmissible illness, al-
ready speculated by Aristotle [2-4]. 
Over the centuries, several attempts to demonstrate that 
“phthisis” was spread through unknown microorganisms 
can be found.
Girolamo Fracastoro (1476-1553) was the first to blame 
an invisible microorganism as a causative agent of tu-
berculosis. Nevertheless, he did not understand that the 
transmission could occur by air. His theory was resumed 
by Benjamin Marten in 1720. He speculated that tuber-
culosis was due to “animacula”, microscopic living be-
ings able to survive in a new body, as a previous theo-
rized by Anton van Leuwenhoek (1632-1723). 
In this age the first theories about tuberculosis arose 
from a careful observation of clinical and anatomic phe-
nomena.
Moreover, a change in the diagnostic approach to the 
disease was happening. In fact, by the end of the eigh-
teenth century tuberculosis was still diagnosed by tho-
racic chest percussion introduced by J. Leopold Auen-
brugger (1722-1809). 
The advent of auscultation, thanks to the invention of 
the stethoscope in 1818 by Renéè Laennec, significantly 
improved the diagnostic path of tuberculosis. Unfortu-
nately, the same Laennec – died at the age of 45 due 
to tuberculosis, presumably as a consequence of close 
contact with contagious patients [5].
Approximately fifty years later, in 1865, Jean Antoine 
Villemin finally proved the infectiousness of the disease 
by combing the clinical observations with laboratory ex-
perimentation on guinea pigs [6, 7].
The path traced by Villemin was completed on the 24th 
of March 1882, when Robert Koch revealed the discov-
ery of “the bacillus responsible of the disease” [8]. 
All debates were suddenly over: tuberculosis is an infec-
tious and contagious disease.
In addition, Koch’s discovery further improved the diag-
nosis of tuberculosis through the microscopic identifica-
tion of the bacillus. The discovery was not well received 
by all the scientific environment: Rudolf Ludwig Karl 
Virchow (1821-1902), who is considered the father of 
social and hygiene medicine, was still claiming the mul-
tifactorial genesis of the illness. 
In fact, he realized that the infection with the bacillus 
was not enough to get sick, but multiple causes contrib-
uted to the development of an active disease.
Moreover, he understood that the presence of what we 
call today the “clinical and social determinants” (immu-
nological status, poverty, malnutrition, lack of hygiene, 
individual behaviors) were strictly related to the devel-
opment of tuberculosis. In other words, he realized the 
systemic complexity of the disease. A few years later, 
in 1895, Wilhem Roentgen, with the X-ray discover, fi-
nally managed to see the damages generated by the dis-
ease [9].
Nowadays, chest X-ray and bacteriological examina-
tion of the expectorate are still the diagnostic tools that 
we use to support and confirm the clinical suspicion of 
tuberculosis. Those confirm the pivotal role of the dis-
covery made by Koch and Roentgen in the fight against 
tuberculosis.
The new awareness of contagiousness, arisen from 
Koch’s discovery, implied the need for patient’s isola-
tion. As a consequence, sanatoriums were then born [10]. 
The recognition of the social determinants that foster the 
disease obliged to provide assistance and preventive in-
TUBERCULOSIS: AN ANCIENT DISEASE AND ETHICAL ISSUE
E17
terventions for the sick and families. Consequently, dis-
pensary networks and hospitals for preventive care were 
established. 
In the history of vaccine and vaccination we remember 
that in 1895 Edoardo Maragliano could announce to the 
scientific community, at the Second Congress of the 
French Society of Internal Medicine, the existence of 
a tubercular antitoxin in infected animals (dogs, asses, 
and hors- es), and the consequent use of animal serum as 
therapeutic agent, by immunizing various animals with 
two different liquid cultures of M. tuberculosis, one of 
which obtained from a heated to 100° C, filtered and 
concentrated culture, the other from a filtered and evapo-
rated culture by vacuum at 30° C [11, 12].
After demonstrating the prophylactic and the protec-
tive effect in guinea pigs, serum was administrated to 
patients: in 1896, Maragliano published data about 412 
patients affected by tuberculosis and treated with serum, 
reporting a complete recovery in 16%, significant im-
provement in 40%, no change in 37% and death in 11%. 
Maragliano also claimed that better results of serum 
therapy were obtained in patients with circumscribed le-
sions with good nutritional conditions than patients with 
diffuse illness [12-14].
In 1896, Maragliano proposed a vaccination practice 
against Mycobacterium tuberculosis: after the adminis-
tration of dead strains in a cohort of children by subcu-
taneous grafting, an increase in the antibody titer was 
found in sera of these children. Nevertheless his discov-
ery was ignored by the scientific community, above all 
because of the large use in the western world of Calmette 
and Guerin (BCG)’s vaccine, made of live strains, from 
1928 [12, 15].
We can therefore say that many efforts have been made 
to fight and win the challenge against this dangerous dis-
ease and now more than ever a clear and decisive joint 
commitment is needed.
The strong social and economic impact that the disease 
still carries today entails forced governments to sensitize 
inhabitants and raise public awareness about prevention 
and treatment.
The great campaign against tuberculosis came to light. 
The same industrial revolution that played a huge part in 
spreading the disease through urbanization facilitated, at 
the same time, a slow economic and social growth that 
resulted in better living and sanitation.
Tuberculosis related mortality reverted its trend and 
began to decrease in the early twentieth century. The 
discovery of effective treatments after the II World War 
allowed the cure of the sick and, at the same time, pre-
vented the transmission.
Progressively, the health and social emergency of the 
“white plague” seemed to be over.
The institutions adapted quickly and sanatoriums were 
closed such as dispensaries which were redirected to 
other functions. Control programs were then targeted 
according to the new epidemiological situation. Today, 
for people living in high income countries, tuberculosis 
is an ancient disease, a memory of the past, a memory 
of time of poverty. Sadly, the current perception of the 
disease is incorrect. Nothing has changed all over the 
planet: those “socio-economical determinants”, intuited 
by Wirchow, still exist today.
Starvation, wars, poverty affect million of people, and 
tuberculosis remains a global health emergency with one 
and a half million death and nine million new patients 
every year, even if new diagnostic tools and effective 
therapies are available [16]. Since the early eighties the 
detrimental intersection between tuberculosis and HIV 
infection posed new diagnostic, therapeutic and manage-
ment challenges. The two diseases since the HIV advent 
appeared clearly to be connected by the same underlying 
“socio-economical determinants”.
Every effort to end these diseases should be collabora-
tive as advocated by the WHO to break the barriers re-
lated to the TB/HIV double stigma [17]. 
Vaccines are important in the prevention and control of 
tuberculosis, but the only now available preventive vac-
cine against TB, bacilli Calmette-Guérin (BCG), is not 
effective for prevention of pulmonary TB. For this rea-
son, it is very important to develop new vaccines for TB 
prevention and control in adults [18].
Around 14 TB vaccine candidates are in this moment 
in clinical evaluation, they can be classified into two 
groups including preventive pre- and post-exposure vac-
cines: subunit vaccines, and whole-cell vaccines [19].
Once again, the problem of tuberculosis is not only a 
medical challenge, but a social, economical and ethical 
issue that needs to be ended [20].
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